AIDS Therapies

Highly Active Antiretroviral Therapy Active Against Kaposi's Sarcoma

Published in Cancer Weekly, September 12th, 2000

Highly active antiretroviral therapy (HAART) is useful against Kaposi's sarcoma (KS), researchers in Italy reported.

"HAART has significantly reduced the KS incidence among HIV infected patients," reported E. Vaccher and colleagues from the Italian Cooperative Group on AIDS and Tumors (GICAT). "To evaluated the anti-KS activity of HAART in patients with NYU stage I-III and slowly progressive disease, we performed a Phase II multicentric study."

Vaccher et al. presented data from their study at the 36th Annual Meeting of the American Society of Clinical Oncology, held in New Orleans, Louisiana. The title of their presentation was "Highly active...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-09-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry